Bottom line
SWISX vs INTF: the short answer
SWISX (Schwab International Index Fund) and INTF (iShares International Equity Factor ETF) share a meaningful slice of their top holdings — about 57% by weight.
SWISX is cheaper at 0.06% vs 0.16% — a difference of $10 a year per $10,000 invested.
Over five years, SWISX returned +9.0% a year vs +4.8% for INTF (reporting dates differ).
Updated Nov 19, 2026
SWISX vs INTF side by side
| SWISX | INTF | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Schwab | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 0.06% | 0.16% |
| Annual cost per $10k | $6 | $16 |
| 10-yr cost on $10k (prospectus) | $77 | $205 |
| Max front load | — | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +31.6% | +5.9% |
| 5-yr return (annualized) | +9.0% | +4.8% |
| 10-yr return (annualized) | +8.3% | — |
| Best quarter | +18.2% | +17.9% |
| Worst quarter | −23.2% | −24.9% |
| Net assets (fund) | $13.6B | $3.6B |
| Number of holdings | 697 | 500 |
| Portfolio turnover | 1% | 21% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SWISX | INTF | Difference |
|---|---|---|---|
| 2024 | +3.5% | +5.9% | −2.4% |
| 2023 | +18.2% | +18.4% | −0.2% |
| 2022 | −14.3% | −12.4% | −1.9% |
| 2021 | +11.3% | +11.5% | −0.2% |
| 2020 | +8.1% | +3.1% | +5.1% |
| 2019 | +21.9% | +18.1% | +3.8% |
| 2018 | −13.3% | −15.7% | +2.3% |
| 2017 | +25.3% | +28.2% | −2.9% |
| 2016 | +1.1% | −0.2% | +1.3% |
Source: Fund prospectus bar charts
Holdings overlap
13 of SWISX's top 25 holdings also appear in INTF's top 25.
| Holding | SWISX | INTF |
|---|---|---|
| ASML Holding NV | 2.58% | 2.35% |
| Roche Holding AG | 1.48% | 1.07% |
| HSBC Holdings PLC | 1.41% | 1.19% |
| AstraZeneca PLC | 1.34% | 0.82% |
| Novartis AG | 1.30% | 2.12% |
| Nestle SA | 1.14% | 0.94% |
| Shell PLC | 1.03% | 0.66% |
| Mitsubishi UFJ Financial Group Inc | 0.96% | 1.04% |
| Novo Nordisk A/S | 0.89% | 0.63% |
| Commonwealth Bank of Australia | 0.80% | 0.67% |
| UBS Group AG | 0.70% | 0.71% |
| Banco Bilbao Vizcaya Argentaria SA | 0.68% | 0.73% |
| TotalEnergies SE | 0.67% | 0.75% |
Source: SEC Form N-PORT
SWISX top 10
- ASML Holding NV — 2.58%
- Roche Holding AG — 1.48%
- HSBC Holdings PLC — 1.41%
- AstraZeneca PLC — 1.34%
- Novartis AG — 1.30%
- Nestle SA — 1.14%
- Siemens AG — 1.06%
- Shell PLC — 1.03%
- Toyota Motor Corp — 0.99%
- Sap Se — 0.96%
INTF top 10
- ASML Holding N.V. — 2.35%
- Novartis AG — 2.12%
- Royal Bank Of Canada — 1.21%
- Hsbc Holdings Plc — 1.19%
- Roche Holding AG — 1.07%
- ABB Ltd — 1.04%
- Mitsubishi UFJ Financial Group, Inc. — 1.04%
- Nestle S.A. — 0.94%
- Bhp Group Limited — 0.93%
- Mizuho Financial Group, Inc. — 0.92%
FAQ
What is the difference between SWISX and INTF?
Which is cheaper, SWISX or INTF?
Should I own both SWISX and INTF?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.